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TCRÇ/CD3, CD28 AND C T L A -4  R E C E P T O R  
SIG N A LLIN G  IN T -C E L L S  C h r is to p h e r  E. R u d d  
Division of T u m o r Im m unology, D a n a -F a rb e r  C an ce r  
Institu te  and  H a rv a rd  M edical School, Boston MA 02115
T-cell activa lion is regulated by a complex inter-play of positive and 
negative signals mediated by TcR-CD3, CD4/CD8, CD28 and CTLA-4. 
TcRÇ/CD3 and CD4/CD8 .signalling involves kinases p56]ck, PI 3- 
kinase, ZAP-70 and downstream substrates such as vav and SLP-76. PI 
3-kinase is recruited via p56]clc and p59f>,fl SH3 domain binding to 
proline residues within the p85 subunit of the enzyme. Within this 
signalling matrix is a recently cloned downstream component termed 
FYB (FYn Binding protein) which has a unique structure, is restricted to 
T and myeloid cells and up-regulates interleukin 2 (IL-2) production.
Despite the intricacies of TcRÇ/CD3-CD4 signalling, optimal T-cell 
stimulation requires co-stimulation mediated by CD28 and other 
receptors. Proximal events of CD28 signalling are initiated by the 
phosphorylation of CD2H at the cytoplasmic pYMNM motif, followed 
3y the recruitment of PI 3-kinase, GRB-2 and T-cell specific protein­
tyrosine kinase (ITK). Although CTLA-4 also binds to PI 3-kinase, it 
negatively regulates the response via engagement of a tyrosine 
phosphatase, mediating an effect on CD28. Distal events of CD28 
signalling include the activation of the serine kinase modules (MAPK, 
SÂPK/JNK, p38), j un phosphorylation and ultimately the initiation’of 
IL-2 transcription. PI 3-kinase may bridge these proximal and distal 
events. Last y, binding to PI 3-kinase implicates CD28 and CTLA-4 in 
functions that have not previously been attributed to these regulators.
S 0 4 6  MECHANISMS OF LYMPHOCYTE HOMING IN CHRONIC
INFLAMMATION.
Costantino Pitzalis. Rheumatology Unît, UMDS Guy's and St.
Thomas Hospitals. St* Thomas Street, London SE1 9RT, UK,
Several chronic systemic diseases are characterized by inflammation which can 
affcct different tissue organs simultaneously. Phenotypic analysis of the 
lymphocytic infiltrate, typically found at sites of chronic inflammation, indicates 
that distinct subsets of lymphocytes accumulate into different tissues such as lung, 
gut, skin and joint. The reasons for this are not completely understood but it is 
thought that regulatory mechanisms intervene at least at three different levels. 
The first level of control relates to specific lymphocyte-endothelial recognition 
systems operating in the microvascular beds of various tissues. These include the 
interaction of lymphocyte "homing" receptors such as L-selectin, CL A and «4p7 
with the respective endothelial "addressin" ligands PNAd, E-selectin and 
MAdCAM-1. A second level of regulation may involve the local production of 
specific chemoattractants capable of recalling lymphocytes programmed to 
recirculate to a given tissue. Although further work is needed in this area it 
appears that some p chemokines can act on distinct subpapulations of 
lymphocytes. Finally, once in the tissues, specific lymphocytes can be 
preferentially retained locally by binding to selective tissue ligands. An example 
of this is represented by aep7 positive lymphocytes which bind gut épithélia E- 
cadherin. Such complex regulation of lymphocyte migration will allow specific 
homing to exist along side universal migration. This will facilitate the 
development of immune responses in specialized compartments while permitting 
their integration throughout the body.
SN44 SIGNAL TRANSDUCTÏON EVENTS ASSOCIATED
SURVIVAL AND DIFFERENTIATION IN PRIMITIVE 
HAEMOPOIETIC CELLS.
A.D. Whetton ■
Leukaemia Research Fund Cellular Development Unit, 
UIVIIST, Manchester M60 1QD.
Haemopoietic stem and progenitor cells require cytokines for îheîr 
survival, proliferation and development. In the absence of these 
cytokines they undergo apoptosis. Molecular mechanisms suppressing 
apoptosis, and their relationship to drug resistance and 
leukaemogenesis have been studied using a haemopoietic stem cell 
line, FDCP-Mix, Cellular signalling events, including the ras/MAP kinase 
pathway, JAK/STAT pathway and also lipid hydrolysis and protein 
kinase C activation have been assessed for their contribution to 
apoptotic suppression. Futhermore the relevance of these pathways to 
the oncogenic activity of the BCR\ABL tyrosine kinase in Chronic 
Myeloid Leukaemia will be discussed. Another aspect of 
leukaemogenesis in the myeloid system is a blockade or disruption of 
development. For this reason we have studied the specific signalling 
events associated with lineage commitment in bipotential haemopoietic 
progenitor cells and present evidence that a specific cytokine- 
stimulated signalling pathway which leads to nuclear translocation of 
a Protein Kinase C isoform activates lineage commitment.
S 0 4 7  ROLE of lfa -i /ic a m  a d h e sio n  in
LEUKOCYTE/STROMAL CELL INTERACTION
Yvette van Koovk. Minke Binnerts and Carl G. Figdor. From the 
Department of Tumor Immunology, University of Nijmegen, Philips van 
Leydenlaan 25,6525 EX Nijmegen, the Netherlands,
The leukocyte integrin LFA-1 (C D lla/C D 18) is a cell surface receptor 
which mediates adhesive interactions and signal transduction in the 
immune system by binding its ligands ICAM-1, -2 or -3 expressed by 
stromal cells. The I domain located in the a  chain (CD 11a) of LFA-1 
(C D lla/C D 18), plays an essential role in ligand recognition. We have 
identified a new site in the I domain that is involved in ICAM-3 binding. A 
synthetic peptide containing the ICAM-3 binding site inhibited ICAM-3 
dependent adhesion and proliferation of resting T cells» suggesting that this 
peptide interferes with immune recognition, and can be used as 
immunosuppressive agents.
Binding of leukocytes to ICAM-3 dramatically induces cell cell interaction 
forming large clusteres. In contrast, when leukocytes adhere to ICAM-1 
all leukocytes spread as single cells. W hen investigating the signaling 
properties o f LFA-1 upon binding to ICAM-1 or ICAM-3 distinct proteins 
become tyrosine phosphorylated. U sing LFA-1 transfectants we 
determined that the cytoplasmic tail of the p chain of LFA-1 is not involved 
in the distinct signaling properties o f LFA-1, indicating that these signals 
are mediated via the cytoplasmic tail o f the a  chian o f LFA-1. The 
evidence that binding of LFA-1 to ICAM-1 or ICAM-3 may generate 
distinct intracellular signals may indicate that the interaction of leukocytes 
to stromal cells that express ICAM molecules may differently guide the 
maturation o f leukocytes.
SN45 REGULATION OF SIGNALING THROUGH THE B LYMPHOCYTE ANTIGEN RECEPTOR COMPLEX.
Edward A. Clark, University of Washington Med. Ctr., Box 357242, Seattle, 
WA 98195, USA
B lymphocytes recognize antigen through surface B cell receptor (BCR) 
complexes. The consequences of ligating the B C R  vary depending on 
the B cell developmental stage: ligating BCRs on immature IgM +IgD“
B cells can lead to activation-induced cell death while ligating BCRs on 
mature germinal center B cells can protect B cells from undergoing 
apoptosis. In this talk I will describe our current thinking about how 
crosslinking the BCR leads to cell death. This process appears to require 
the protein tyrosine kinase Syk and phospholipase C y l/2  (which are 
activated by Syk) and downstream members of the MAP kinase-related 
family of ser/thr kinases such as the p38 kinase. A novel member of the 
protein kinase C (PKC) family, PKCp., appears to regulate this pathway. 
Much as adverbs can modify transitive verbs, the actions induced via the 
BCR can be modified by B cell-associated surface molecules such as 
CD 19, CD22 and CD40, CD45. Tn particular, our studies with CD22- 
deficient mice suggest that CD22 acts as an 'adverb' to slow down the 
BCR-mediated 'die1 action. It may do so via a protein tyrosine 
phosphatase, SH P-1, which is recruited into and activated within a 
CD22 complex after BCR ligation. By contrast, the CD40 'modifier' 
apparently acts later in time to affect cell fate by altering BCR-induced 
MAPK-related and c-Myc-related signaling pathways. Insights into how 
the BCR 'sentences' are constructed may lead to new ways to modify 
defective messages in lymphomas and autoreactive B cells.
S 048 FIBROCYTES: NOVEL, CIRCULATING FIBROBLAST­
LIKE CELLS WITH POTENT ANTIGEN PRESENTATION 
PROPERTIES.
RICHARD BUCALA, The Picower Institute for Medical Research, 
350 Community Drive, Manhasset, New York, USA 10030.
We recently described a population of novel, circulating cells 
that rapidly enter sites of tissue injury, synthesize connective 
tissue matrix, and can be localized to sites of fibrosis and scar­
ring (Mol Medicine 1994; 1:71-81). Coined "fibrocytes", these 
cells constitute 0.03-0.3% of blood-borne leukocytes and display 
a distinct cell surface phenotype (collagen+/CD13+/CD34+/CD- 
45+/esterase~/cytokeratin“/von Willebrand”/a-actin~/CD14~/CD- 
16~/CD25“/CD54~). Fibrocytes purified from peripheral blood 
secrete both pro-inflammatory and fibrogenic cytokines in a re­
gulated fashion and can be shown to have potent antigen pre­
sentation properties. Recent immunohistochemical studies have 
shown fibrocytes to be present in scarred skin, the hepatic gra­
nulomas of Schistosomias, and the intraluminal plaque of athero­
sclerotic vessels. The identification of the fibrocyte as a distinct, 
blood-borne cell that participates in both the immune and the 
repair phases of tissue injury suggests that these cells play a 
critical role in a variety of host responses.
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